Quarterly Consolidated Balance Sheet

Immuno-Biological Laboratories Co., Ltd. - Filing #7590343

Concept As at
2022-06-30
As at
2022-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
463,253,000 JPY
508,350,000 JPY
Merchandise and finished goods
46,800,000 JPY
47,380,000 JPY
Work in process
136,883,000 JPY
133,314,000 JPY
Raw materials and supplies
155,607,000 JPY
145,892,000 JPY
Other
124,203,000 JPY
120,978,000 JPY
Current assets
1,104,021,000 JPY
1,129,786,000 JPY
Non-current assets
Property, plant and equipment
119,277,000 JPY
120,081,000 JPY
Property, plant and equipment
Land
119,277,000 JPY
120,081,000 JPY
Investments and other assets
426,245,000 JPY
455,471,000 JPY
Investments and other assets
Investment securities
370,783,000 JPY
399,818,000 JPY
Other
55,461,000 JPY
55,652,000 JPY
Non-current assets
545,522,000 JPY
575,552,000 JPY
Assets
1,649,544,000 JPY
1,705,338,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
9,690,000 JPY
3,930,000 JPY
Short-term borrowings
125,000,000 JPY
125,000,000 JPY
Other
80,515,000 JPY
77,960,000 JPY
Current liabilities
232,218,000 JPY
228,083,000 JPY
Non-current liabilities
Long-term borrowings
103,988,000 JPY
104,990,000 JPY
Retirement benefit liability
3,927,000 JPY
3,917,000 JPY
Non-current liabilities
107,915,000 JPY
108,907,000 JPY
Liabilities
340,133,000 JPY
336,990,000 JPY
Net assets
Shareholders' equity
Share capital
3,029,041,000 JPY
3,029,041,000 JPY
Capital surplus
2,061,421,000 JPY
2,061,421,000 JPY
Retained earnings
-3,779,062,000 JPY
-3,720,124,000 JPY
Treasury shares
-1,990,000 JPY
-1,990,000 JPY
Shareholders' equity
1,309,411,000 JPY
1,368,348,000 JPY
Net assets
1,309,411,000 JPY
1,368,348,000 JPY
Liabilities and net assets
1,649,544,000 JPY
1,705,338,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.